Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: The aim of this work is to evaluate the efficacy of cytoreductive surgery alone versus cytoreductive surgery in combination with hyperthermic intraperitoneal chemotherapy (HIPEC), on patient benefits, complications and short-term outcomes in patients with pseudomyxoma peritonei (PMP). \ua9 2018 The Cochrane Collaboration